Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80039318
- Market status:
- Not Marketed
- Licence Status:
- Active
- Brand name(s):
-
Gynophilus
;
Provacare - Licence holder:
- Biose Industrie
- Dosage Form:
- Ovule
- Recommended route of administration:
-
Vaginal
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adult Females | 1.0 | Ovule | 2 | daily | ||||||||
Adult Females | 1.0 | Ovule | 2 | daily | ||||||||
- Recommended use or purpose:
- Helps in the treatment of recurrent vaginal mycosis (yeast infection). Helps to treat symptoms of yeast infections including: excessive discharge, burning and vaginal dryness. Helps to restore normal healthy vaginal flora following antibiotic treatment. To help treat bacterial vaginosis after initial treatment with antibiotics. Adjunct therapy to help treat bacterial vaginosis. Adjunct therapy to help prevent recurrent vaginal mycosis (yeast infection).
- Risk Information:
- Cautions and Warnings
- This product has come into contact with milk. Do not use this product if you have a milk allergy. If you have nausea, fever, vomiting, bloody diarrhea or severe abdominal pain, consult a health care practitioner prior to use. Do not use if you have an immune-compromised condition (e.g., AIDS, lymphoma, patients undergoing long-term corticosteroid treatment). Consult a health care practitioner prior to use if you are pregnant. Take Provacare 2-3 hours before or after taking an antibiotic. Do not use if the bottle safety seal is broken or missing. Store out of reach of children.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
Lactobacillus rhamnosus |
10.0 billion cfu
|
- List of non-medicinal ingredients:
-
- Calcium Hydroxide
- Dextrin
- Gelatin
- Lactose
- Magnesium Stearate
- Maltose
- Potato starch
- Sodium glutamate
- Sodium thiosulfate
- Date of licensing:
- 2013-01-30
- Revised date of licence:
- 2017-11-15
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).